Echothiophate is primarily indicated for which condition?

Echothiophate is primarily indicated for the management of accommodative esotropia. This condition involves misalignment of the eyes, where one eye turns inward due to difficulties with focusing. Echothiophate, an acetylcholinesterase inhibitor, enhances the effects of acetylcholine at the neuromuscular junction, leading to increased muscle contraction, particularly in the ciliary muscle, which helps in accommodative adjustment. By improving the eye's ability to focus, echothiophate can help correct the strabismus seen in accommodative esotropia.

In addition to its role in treating accommodative esotropia, echothiophate also has implications in glaucoma treatment due to its ability to promote miosis and potentially reduce intraocular pressure, but its primary indication remains in strabismus management.